These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35972707)

  • 1. CRISPR/Cas9-mediated knockout of HO-1 decreased the proliferation and migration of T47D cells and increased cisplatin-induced apoptosis: an in vitro study.
    Evazi Bakhshi S; Mohammadi Roushandeh A; Habibi Roudkenar M; Shekarchi S; Bahadori MH
    Med Oncol; 2022 Aug; 39(11):175. PubMed ID: 35972707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
    Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
    Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
    Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
    Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
    Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
    Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological versus genetic inhibition of heme oxygenase-1 - the comparison of metalloporphyrins, shRNA and CRISPR/Cas9 system.
    Mucha O; Podkalicka P; Czarnek M; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Stepniewski J; Jozkowicz A; Dulak J; Loboda A
    Acta Biochim Pol; 2018; 65(2):277-286. PubMed ID: 29694447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 mediated knocking out of OPN gene enhances radiosensitivity in MDA-MB-231 breast cancer cell line.
    Ghanbarnasab Behbahani R; Danyaei A; Teimoori A; Tahmasbi MJ; Neisi N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4117-4130. PubMed ID: 36042045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase.
    Hill M; Pereira V; Chauveau C; Zagani R; Remy S; Tesson L; Mazal D; Ubillos L; Brion R; Asghar K; Mashreghi MF; Kotsch K; Moffett J; Doebis C; Seifert M; Boczkowski J; Osinaga E; Anegon I
    FASEB J; 2005 Dec; 19(14):1957-68. PubMed ID: 16319139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of a Chinese medicine Xiaoaiping combined with cisplatin on the proliferation, invasion and apoptosis in ovarian cancer HO-8910 PM cells in vitro and in vivo].
    Zheng A; Li T; Chen Y; Fang J; Zhang Y; Feng J
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):11-6. PubMed ID: 26796800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
    Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
    Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin.
    Kim HR; Kim S; Kim EJ; Park JH; Yang SH; Jeong ET; Park C; Youn MJ; So HS; Park R
    Lung Cancer; 2008 Apr; 60(1):47-56. PubMed ID: 18006113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial characteristics contribute to proliferation and migration potency of MDA-MB-231 cancer cells and their response to cisplatin treatment.
    Kheirandish-Rostami M; Roudkenar MH; Jahanian-Najafabadi A; Tomita K; Kuwahara Y; Sato T; Roushandeh AM
    Life Sci; 2020 Mar; 244():117339. PubMed ID: 31972210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screening.
    Sui X; Tang X; Wu X; Liu Y
    Biochem Biophys Res Commun; 2022 Feb; 593():84-92. PubMed ID: 35063774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide CRISPR/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis.
    Wang L; Zhou L; Li M; Zhao J; Liu Y; Chen Y; Qin X; Wang S; Chen H; Piao Y; Xiang R; Li J; Shi Y
    Biochem Biophys Res Commun; 2022 Jan; 589():107-115. PubMed ID: 34902746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation.
    Jo EJ; Park SJ; Kim BC
    Eur J Pharmacol; 2016 Oct; 788():321-327. PubMed ID: 27375080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells.
    Kuroda H; Takeno M; Murakami S; Miyazawa N; Kaneko T; Ishigatsubo Y
    Lung Cancer; 2010 Jan; 67(1):31-6. PubMed ID: 19375813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to pharmorubicin by promoting autophagy via PI3K/Akt pathway.
    Pei L; Kong Y; Shao C; Yue X; Wang Z; Zhang N
    J Cell Mol Med; 2018 Nov; 22(11):5311-5321. PubMed ID: 30216645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.
    Luo P; Wu S; Ji K; Yuan X; Li H; Chen J; Tian Y; Qiu Y; Zhong X
    PLoS One; 2020; 15(11):e0223035. PubMed ID: 33232319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation.
    Kim HJ; So HS; Lee JH; Lee JH; Park C; Park SY; Kim YH; Youn MJ; Kim SJ; Chung SY; Lee KM; Park R
    Free Radic Biol Med; 2006 May; 40(10):1810-9. PubMed ID: 16678019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.